← Back to headlines
Aurinia Settles Lupkynis Patent Litigation with Teva
Aurinia Pharmaceuticals has reached a settlement in its patent litigation concerning Lupkynis with Teva Pharmaceutical Industries.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
August Manufacturing PMI Data Reveals Divergent Global Economic Performance
28m ago
Shein’s Hong Kong IPO Debut Underwhelms Amid Geopolitical Risks and New Fashion Levies
29m ago
Wall Street Futures Drop as Rising Yields and Oil Prices Weigh on Markets
44m ago
IKEA Launches €1.2 Billion Price Cut Campaign Across Europe
49m ago